DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas

by Signe Regner Michaelsen, Derya Aslan, Thomas Urup, Hans Skovgaard Poulsen, Kirsten Grønbæk, Helle Broholm, Lasse Sommer Kristensen
Published 2018-02-01

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution

by Armita Armina Abedi, Armita Armina Abedi, Kirsten Grunnet, Kirsten Grunnet, Ib Jarle Christensen, Signe Regner Michaelsen, Signe Regner Michaelsen, Aida Muhic, Søren Møller, Søren Møller, Benedikte Hasselbalch, Benedikte Hasselbalch, Hans Skovgaard Poulsen, Hans Skovgaard Poulsen, Thomas Urup, Thomas Urup
Published 2021-02-01

18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.

by Mette Kjoelhede Nedergaard, Signe Regner Michaelsen, Thomas Urup, Helle Broholm, Henrik El Ali, Hans Skovgaard Poulsen, Marie-Thérése Stockhausen, Andreas Kjaer, Ulrik Lassen
Published 2015-01-01

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

by Thomas Urup, Linn Gillberg, Katja Kaastrup, Maya Jeje Schuang Lü, Signe Regner Michaelsen, Vibeke Andrée Larsen, Ib Jarle Christensen, Helle Broholm, Ulrik Lassen, Kirsten Grønbæk, Hans Skovgaard Poulsen
Published 2020-05-01

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

by Thomas Urup, Line Mærsk Staunstrup, Signe Regner Michaelsen, Kristoffer Vitting-Seerup, Marc Bennedbæk, Anders Toft, Lars Rønn Olsen, Lars Jønson, Shohreh Issazadeh-Navikas, Helle Broholm, Petra Hamerlik, Hans Skovgaard Poulsen, Ulrik Lassen
Published 2017-04-01